Sign Up Today and Learn More About Infusionsoft Stock
Invest in or calculate the value of your shares in Infusionsoft or other pre-IPO companies through EquityZen's platform.
Infusionsoft Stock (INFU)
Sales and marketing automation services
About Infusionsoft Stock
Founded
2001
Headquarters
Chandler, AZ, US
Total Funding
148M
Industries
Software, Sales and Marketing, Information Technology
Infusionsoft provides an all-in-one sales and marketing software for small businesses. Its Web-based solution helps small businesses automatically market to get more customers, grow sales and save time. The privately held, seven-time Inc. 500/5000 company is based in Chandler, Ariz. and is funded by Goldman Sachs, Mohr Davidow Ventures and Signal Peak Ventures.
Infusionsoft Press Mentions
Stay in the know about the latest news on Infusionsoft
Keap Announces Robert Herjavec from 'Shark Tank' as Keynote Speaker for Let's Grow Summit 2024
prnewswire • Aug 05, 2024
Virtual Work Wife Announces the Publication of Michelle Bell’s Newest Book
theglobeandmail • Aug 05, 2024
Keap CRM Review (2024): Features, Pricing, Pros & Cons
techrepublic • Jun 19, 2024
Keap Creates Complete Business Automation and Payment Tools to Empower Employees and Wow Clients
cardrates • Jun 04, 2024
Keap Recognized as a 2024 G2 Best Software Awards Recipient and in 274 Spring G2 2024 Reports
streetinsider • Jun 04, 2024
Investors in Infusionsoft
Discover investors in Infusionsoft stock and explore their portfolio companies
Infusionsoft Management
Leadership team at Infusionsoft
Founder, VP Customer Service
Scott Martineau
Chief Product Officer
Terry Hicks
Join now and verify your accreditation status to gain access to:
- Infusionsoft current valuation
- Infusionsoft stock price
- Available deals in Infusionsoft and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Infusionsoft stock?
Accredited investors can buy pre-IPO stock in companies like Infusionsoft through EquityZen funds. These investments are made available by existing Infusionsoft shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Infusionsoft stock?
Shareholders can sell their Infusionsoft stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
